Novel entries in a fungal biofilm matrix encyclopedia

mBio

Volumn 5, Issue 4, 2014, Pages 1-13

  Zarnowski, Robert ^a   Westler, William M ^b   Lacmbouh, Ghislain Ade ^b   Marita, Jane M ^c   Bothe, Jameson R ^b   Bernhardt, Jörg ^d,e   Sahraoui, Anissa Lounes Hadj ^f   Fontainei, J ^f   Sanchez, Hiram ^a   Hatfeld, Ronald D ^c   Ntambi, James M ^b   Nett, Jeniel E ^a,b   Mitchell, Aaron P ^g   Andes, David R ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c U S DAIRY FORAGE RESEARCH CENTER   (United States)

^d UNIVERSITY OF GREIFSWALD   (Germany)

^e DECODON GmbH   (Germany)

^f UNIVERSITÉ DU LITTORAL CÔTE D OPALE   (France)

^g CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BETA 1,3 GLUCAN; BETA 1,6 GLUCAN; FLUCONAZOLE; GLYCEROLIPID; MANNAN; SPHINGOLIPID; ANTIFUNGAL AGENT; FUNGAL PROTEIN;

ANTIFUNGAL RESISTANCE; ARTICLE; BIOCHEMICAL COMPOSITION; BIOFILM MATRIX; CANDIDA ALBICANS; CONTROLLED STUDY; DNA SEQUENCE; FUNGAL PHENOMENA AND FUNCTIONS; IN VITRO STUDY; LIPID ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PROTEIN ANALYSIS; BIOFILM; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PROCEDURES; PROTEOMICS;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; PROTEOMICS;

EID: 84908267869     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01333-14     Document Type: Article

References (88)

1. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322. http://dx.doi.org/10.1126/science.284.5418.1318.
2. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193. http://dx.doi.org/10.1128/CMR.15.2.167-193.2002.
3. Potera C. 1999. Forging a link between biofilms and disease. Science 283:1837-1839. http://dx.doi.org/10.1126/science.283.5409.1837.
4. Branda SS, Vik S, Friedman L, Kolter R. 2005. Biofilms: the matrix revisited. Trends Microbiol. 13:20-26. http://dx.doi.org/10.1016/j.tim.2004.11.006.
5. Flemming HC, Wingender J. 2010. The biofilm matrix. Nat. Rev. Microbiol. 8:623-633.
6. Douglas LJ. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11:30-36. http://dx.doi.org/10.1016/S0966-842X(02)00002-1.
7. Pfaller MA, Diekema DJ. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20:133-163. http://dx.doi.org/10.1128/CMR.00029-06.
8. Al-Fattani MA, Douglas LJ. 2004. Penetration of Candida biofilms by antifungal agents. Antimicrob. Agents Chemother. 48:3291-3297. http://dx.doi.org/10.1128/AAC.48.9.3291-3297.2004.
9. Vediyappan G, Rossignol T, d’Enfert C. 2010. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans. Antimicrob. Agents Chemother. 54: 2096-2111. http://dx.doi.org/10.1128/AAC.01638-09.
10. Nett JE, Sanchez H, Cain MT, Andes DR. 2010. Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J. Infect. Dis. 202:171-175. http://dx.doi.org/10.1086/651200.
11. Nett JE, Crawford K, Marchillo K, Andes DR. 2010. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrob. Agents Chemother. 54:3505-3508. http://dx.doi.org/10.1128/AAC.00227-10.
12. Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, Hoff B, Van-Handel M, Andes D. 2007. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob. Agents Chemother. 51:510-520. http://dx.doi.org/10.1128/AAC.01056-06.
13. Taff HT, Nett JE, Zarnowski R, Ross KM, Sanchez H, Cain MT, Hamaker J, Mitchell AP, Andes DR. 2012. A candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog. 8:e1002848. http://dx.doi.org/10.1371/journal.ppat.1002848.
14. Nobile CJ, Nett JE, Hernday AD, Homann OR, Deneault JS, Nantel A, Andes D., Johnson AD, Mitchell AP. 2009. Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol. 7:e1000133. http://dx.doi.org/10.1371/journal.pbio.1000133.
15. Shibata N, Kobayashi H, Okawa Y, Suzuki S. 2003. Existence of novel beta-1,2 linkage-containing side chain in the mannan of Candida lusitaniae, antigenically related to Candida albicans serotype A. Eur. J. Biochem. 270:2565-2575. http://dx.doi.org/10.1046/j.1432-1033.2003.03622.x.
16. Shibata N, Okawa Y. 2010. Conformational analysis of beta-1,2-linked mannobiose to mannoheptaose, specific antigen of pathogenic yeast Candida albicans. Chem. Pharm. Bull. 58:1386-1390. http://dx.doi.org/10.1248/cpb.58.1386.
17. Shibata N, Suzuki A, Kobayashi H, Okawa Y. 2007. Chemical structure of the cell wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms. Biochem. J. 404:365-372. http://dx.doi.org/10.1042/BJ20070081.
18. Lowman DW, West LJ, Bearden DW, Wempe MF, Power TD, Ensley HE, Haynes K, Williams DL, Kruppa MD. 2011. New insights into the structure of (1→3,1→6)-beta-D-glucan side chains in the Candida glabrata cell wall. PLoS One 6:e27614. http://dx.doi.org/10.1371/journal.pone.0027614.
19. Lowman DW, Ensley HE, Greene RR, Knagge KJ, Williams DL, Kruppa MD. 2011. Mannan structural complexity is decreased when Candida albicans is cultivated in blood or serum at physiological temperature. Carbohydr. Res. 346:2752-2759. http://dx.doi.org/10.1016/j.carres.2011.09.029.
20. Takahashi S, Kudoh A, Okawa Y, Shibata N. 2012. Significant differences in the cell wall mannans from three Candida glabrata strains correlate with antifungal drug sensitivity. FEBS J. 279:1844-1856. http://dx.doi.org/10.1111/j.1742-4658.2012.08564.x.
21. Bernhardt JFS, Hecker M, Siebourg J. 2009. Visualizing gene expression data via Voronoi treemaps, p 233-241. In Sixth International Symposium on Voronoi diagrams. IEEE, Piscataway, NJ. http://dx.doi.org/10.1109/ISVD.2009.33.
22. Peltroche-Llacsahuanga H, Goyard S, d’Enfert C, Prill SK, Ernst JF. 2006. Protein O-mannosyltransferase isoforms regulate biofilm formation in Candida albicans. Antimicrob. Agents Chemother. 50:3488-3491. http://dx.doi.org/10.1128/AAC.00606-06.
23. Martins M, Uppuluri P, Thomas DP, Cleary IA, Henriques M, Lopez-Ribot JL, Oliveira R. 2010. Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms. Mycopathologia 169:323-331. http://dx.doi.org/10.1007/s11046-009-9264-y.
24. Flemming HC, Neu TR, Wozniak DJ. 2007. The EPS matrix: the “house of biofilm cells.” J. Bacteriol. 189:7945-7947. http://dx.doi.org/10.1128/JB.00858-07.
25. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O’Toole GA. 2003. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426:306-310. http://dx.doi.org/10.1038/nature02122.
26. Al-Fattani MA, Douglas LJ. 2006. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J. Med. Microbiol. 55:999-1008. http://dx.doi.org/10.1099/jmm.0.46569-0.
27. Kojic EM, Darouiche RO. 2004. Candida infections of medical devices. Clin. Microbiol. Rev. 17:255-267. http://dx.doi.org/10.1128/CMR.17.2.255-267.2004.
28. Robbins N, Uppuluri P, Nett J, Rajendran R, Ramage G, Lopez-Ribot JL, Andes D, Cowen LE. 2011. Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog. 7:e1002257. http://dx.doi.org/10.1371/journal.ppat.1002257.
29. Donlan RM. 2001. Biofilm formation: a clinically relevant microbiological process. Clin. Infect. Dis. 33:1387-1392. http://dx.doi.org/10.1086/322972.
30. O’Toole GA. 2003. To build a biofilm. J. Bacteriol. 185:2687-2689. http://dx.doi.org/10.1128/JB.185.9.2687-2689.2003.
31. Rajendran R, Williams C, Lappin DF, Millington O, Martins M, Ramage G. 2013. Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms. Eukaryot. Cell 12: 420-429. http://dx.doi.org/10.1128/EC.00287-12.
32. Colvin KM, Gordon VD, Murakami K, Borlee BR, Wozniak DJ, Wong GC, Parsek MR. 2011. The Pel polysaccharide can serve a structural and protective role in the biofilm matrix of Pseudomonas aeruginosa. PLoS Pathog. 7:e1001264. http://dx.doi.org/10.1371/journal.ppat.1001264.
33. Colvin KM, Irie Y, Tart CS, Urbano R, Whitney JC, Ryder C, Howell PL, Wozniak DJ, Parsek MR. 2012. The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix. Environ. Microbiol. 14:1913-1928. http://dx.doi.org/10.1111/j.1462-2920.2011.02657.x.
34. Beauvais A, Loussert C, Prevost MC, Verstrepen K, Latgé JP. 2009. Characterization of a biofilm-like extracellular matrix in FLO1-expressing Saccharomyces cerevisiae cells. FEMS Yeast Res. 9:411-419. http://dx.doi.org/10.1111/j.1567-1364.2009.00482.x.
35. Loussert C, Schmitt C, Prevost MC, Balloy V, Fadel E, Philippe B, Kauffmann-Lacroix C, Latgé JP, Beauvais A. 2010. In vivo biofilm composition of Aspergillus fumigatus. Cell. Microbiol. 12:405-410. http://dx.doi.org/10.1111/j.1462-5822.2009.01409.x.
36. Chaffin WL, López-Ribot JL, Casanova M, Gozalbo D, Martínez JP. 1998. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol. Mol. Biol. Rev. 62:130-180.
37. Kapteyn JC, Hoyer LL, Hecht JE, Müller WH, Andel A, Verkleij AJ, Makarow M, Van Den Ende H, Klis FM. 2000. The cell wall architecture of Candida albicans wild-type cells and cell wall-defective mutants. Mol. Microbiol. 35:601-611.
38. Klis FM, de Groot P, Hellingwerf K. 2001. Molecular organization of the cell wall of Candida albicans. Med. Mycol. 39(Suppl 1):1-8. http://dx.doi.org/10.1080/744118879.
39. Davies DG, Marques CN. 2009. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J. Bacteriol. 191:1393-1403. http://dx.doi.org/10.1128/JB.01214-08.
40. Davey ME, Caiazza NC, O’Toole GA. 2003. Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J. Bacteriol. 185:1027-1036. http://dx.doi.org/10.1128/JB.185.3.1027-1036.2003.
41. Lattif AA, Mukherjee PK, Chandra J, Roth MR, Welti R, Rouabhia M, Ghannoum MA. 2011. Lipidomics of Candida albicans biofilms reveals phase-dependent production of phospholipid molecular classes and role for lipid rafts in biofilm formation. Microbiology 157:3232-3242. http://dx.doi.org/10.1099/mic.0.051086-0.
42. Bink A, Kucharíková S, Neirinck B, Vleugels J, Van Dijck P, Cammue BP, Thevissen K. 2012. The nonsteroidal anti-inflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms. J. Infect. Dis. 206:1790-1797. http://dx.doi.org/10.1093/infdis/jis594.
43. Ghalehnoo ZR, Rashki A, Najimi M, Dominguez A. 2010. The role of diclofenac sodium in the dimorphic transition in Candida albicans. Microb. Pathog. 48:110-115. http://dx.doi.org/10.1016/j.micpath.2009.12.003.
44. Branda SS, Chu F, Kearns DB, Losick R, Kolter R. 2006. A major protein component of the Bacillus subtilis biofilm matrix. Mol. Microbiol. 59: 1229-1238. http://dx.doi.org/10.1111/j.1365-2958.2005.05020.x.
45. Thomas DP, Bachmann SP, Lopez-Ribot JL. 2006. Proteomics for the analysis of the Candida albicans biofilm lifestyle. Proteomics 6:5795-5804. http://dx.doi.org/10.1002/pmic.200600332.
46. Martínez-Gomariz M, Perumal P, Mekala S, Nombela C, Chaffin WL, Gil C. 2009. Proteomic analysis of cytoplasmic and surface proteins from yeast cells, hyphae, and biofilms of Candida albicans. Proteomics 9:2230-2252. http://dx.doi.org/10.1002/pmic.200700594.
47. Nobile CJ, Andes D., Nett JE, Smith F., Yue F, Phan QT, Edwards JE, Filler SG, Mitchell AP. 2006. Critical role of Bcr1-dependent adhesins in C. Albicans biofilm formation in vitro and in vivo. PLoS Pathog. 2:e63. http://dx.doi.org/10.1371/journal.ppat.0020063.
48. Nobile CJ, Mitchell AP. 2005. Regulation of cell-surface genes and biofilm formation by the C. Albicans transcription factor Bcr1p. Curr. Biol. 15:1150-1155. http://dx.doi.org/10.1016/j.cub.2005.05.047.
49. Liu Y, Filler SG. 2011. Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryot. Cell 10:168-173. http://dx.doi.org/10.1128/EC.00279-10.
50. Sutherland IW. 2001. The biofilm matrix—an immobilized but dynamic microbial environment. Trends Microbiol. 9:222-227. http://dx.doi.org/10.1016/S0966-842X(01)02012-1.
51. Absalon C, Ymele-Leki P, Watnick PI. 2012. The bacterial biofilm matrix as a platform for protein delivery. mBio 3(4):. http://dx.doi.org/10.1128/mBio.00127-12e00127-00112.
52. Romani AM, Fund K, Artigas J, Schwartz T, Sabater S, Obst U. 2008. Relevance of polymeric matrix enzymes during biofilm formation. Microb. Ecol. 56:427-436. http://dx.doi.org/10.1007/s00248-007-9361-8.
53. Jiao Y, D’Haeseleer P, Dill BD, Shah M, Verberkmoes NC, Hettich RL, Banfield JF, Thelen MP. 2011. Identification of biofilm matrix-associated proteins from an acid mine drainage microbial community. Appl. Environ. Microbiol. 77:5230-5237. http://dx.doi.org/10.1128/AEM.03005-10.
54. Chen C, Krishnan V, Macon K, Manne K, Narayana SV, Schneewind O. 2013. Secreted proteases control autolysin-mediated biofilm growth of Staphylococcus aureus. J. Biol. Chem. 288:29440-29452. http://dx.doi.org/10.1074/jbc.M113.502039.
55. Nosanchuk JD, Nimrichter L, Casadevall A, Rodrigues ML. 2008. A role for vesicular transport of macromolecules across cell walls in fungal pathogenesis. Commun. Integr. Biol. 1:37-39. http://dx.doi.org/10.4161/cib.1.1.6639.
56. Nombela C, Gil C, Chaffin WL. 2006. Non-conventional protein secretion in yeast. Trends Microbiol. 14:15-21. http://dx.doi.org/10.1016/j.tim.2005.11.009.
57. Nickel W, Rabouille C. 2009. Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell Biol. 10:148-155. http://dx.doi.org/10.1038/nrm2617.
58. Sutherland I. 2001. Biofilm exopolysaccharides: a strong and sticky framework. Microbiology 147:3-9.
59. Ramage G, Rajendran R, Sherry L, Williams C. 2012. Fungal biofilm resistance. Int. J. Microbiol. 2012:528521. http://dx.doi.org/10.1155/2012/528521.
60. Mah TF, O’Toole GA. 2001. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9:34-39. http://dx.doi.org/10.1016/S0966-842X(00)01913-2.
61. Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA. 2003. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect. Immun. 71: 4333-4340. http://dx.doi.org/10.1128/IAI.71.8.4333-4340.2003.
62. Ramage G, Bachmann S, Patterson TF, Wickes BL, López-Ribot JL. 2002. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J. Antimicrob. Chemother. 49: 973-980. http://dx.doi.org/10.1093/jac/dkf049.
63. Martins M, Henriques M, Lopez-Ribot JL, Oliveira R. 2012. Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms. Mycoses 55:80-85. http://dx.doi.org/10.1111/j.1439-0507.2011.02047.x.
64. Andes D, van Ogtrop M. 1999. Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model. Antimicrob. Agents Chemother. 43: 2116-2120.
65. Dubois M, Gilles K, Hamilton JK, Rebers PA, Smith F. 1951. A colorimetric method for the determination of sugars. Nature 168:167. http://dx.doi.org/10.1038/168167b0.
66. Henry RJ, Blakeney AB, Harris PJ, Stone BA. 1983. Detection of neutral and aminosugars from glycoproteins and polysaccharides as their alditol acetates. J. Chromatogr. 256:419-427. http://dx.doi.org/10.1016/S0021-9673(01)88259-5.
67. Sassaki GL, Gorin PA, Souza LM, Czelusniak PA, Iacomini M. 2005. Rapid synthesis of partially O-methylated alditol acetate standards for GC-MS: some relative activities of hydroxyl groups of methyl glycopyranosides on Purdie methylation. Carbohydr. Res. 340:731-739. http://dx.doi.org/10.1016/j.carres.2005.01.020.
68. Nett J, Lincoln L, Marchillo K, Andes D. 2007. Beta-1,3 glucan as a test for central venous catheter biofilm infection. J. Infect. Dis. 195: 1705-1712. http://dx.doi.org/10.1086/517522.
69. Petoukhov MV, Svergun DI. 2013. Applications of small-angle X-ray scattering to biomacromolecular solutions. Int. J. Biochem. Cell Biol. 45: 429-437. http://dx.doi.org/10.1016/j.biocel.2012.10.017.
70. König S, Svergun D, Koch MH, Hübner G, Schellenberger A. 1992. Synchrotron radiation solution X-ray scattering study of the pH dependence of the quaternary structure of yeast pyruvate decarboxylase. Biochemistry 31:8726-8731. http://dx.doi.org/10.1021/bi00152a007.
71. Van Le B, Franke D, Svergun DI, Han T, Hwang HY, Kim KK. 2009. Structural and functional characterization of soluble endoglin receptor. Biochem. Biophys. Res. Commun. 383:386-391. http://dx.doi.org/10.1016/j.bbrc.2009.02.162.
72. Yokoyama WM. 2001. Production of monoclonal antibodies. Curr. Protocols Immunol. 2:11:2.5. http://dx.doi.org/10.1002/0471142735.im0205s03.
73. Zarnowski R, Jaromin A, Certik M, Czabany T, Fontaine J, Jakubik T, Iqbal MC, Grandmougin-Ferjani A, Kozubek A, Pietr SJ. 2004. The oil of Adenanthera pavonina L. seeds and its emulsions. Z. Naturforsch. C 59:321-326.
74. Zarnowski R, Connolly PA, Wheat LJ, Woods JP. 2007. Production of extracellular proteolytic activity by Histoplasma capsulatum grown in Histoplasma-macrophage medium is limited to restriction fragment length polymorphism class 1 isolates. Diagn. Microbiol. Infect. Dis. 59: 39-47. http://dx.doi.org/10.1016/j.diagmicrobio.2007.03.020.
75. Zarnowski R, Ellis RJ, Lewicka T, Pietr SJ. 2004. Effect of age on the fatty acid composition of the Bacillus subtilis PO270 isolated from wheat rhizosphere. Pol. J. Microbiol. 53:267-272.
76. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85. http://dx.doi.org/10.1016/0003-2697(85)90442-7.
77. Martin SE, Shabanowitz J, Hunt DF, Marto JA. 2000. Subfemtomole MS and MS/MS peptide sequence analysis using nano-HPLC micro-ESI Fou-rier transform ion cyclotron resonance mass spectrometry. Anal. Chem. 72:4266-4274. http://dx.doi.org/10.1021/ac000497v.
78. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. 1999. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20:3551-3567. http://dx.doi.org/10.1002/(SICI)1522-2683(19991201)20:18_3551::AID-ELPS3551_3.0.CO;2-2.
79. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. 2002. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74:5383-5392. http://dx.doi.org/10.1021/ac025747h.
80. Kanehisa M, Goto S. 2000. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27-30. http://dx.doi.org/10.1093/nar/28.7.e27.
81. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. 2012. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 40:D109-D114. http://dx.doi.org/10.1093/nar/gkr988.
82. Sandhu LC, Warters RL, Dethlefsen LA. 1985. Fluorescence studies of Hoechst 33342 with supercoiled and relaxed plasmid pBR322 DNA. Cytometry 6:191-194. http://dx.doi.org/10.1002/cyto.990060304.
83. Inglis DO, Arnaud MB, Binkley J, Shah P, Skrzypek MS, Wymore F, Binkley G, Miyasato SR, Simison M, Sherlock G. 2012. The Candida genome database incorporates multiple Candida species: multispecies search and analysis tools with curated gene and protein information for Candida albicans and Candida glabrata. Nucleic Acids Res. 40: D667-D674. http://dx.doi.org/10.1093/nar/gkr945.
84. Andes D, Nett J, Oschel P, Albrecht R, Marchillo K, Pitula A. 2004. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect. Immun. 72:6023-6031. http://dx.doi.org/10.1128/IAI.72.10.6023-6031.2004.
85. Nett JE, Marchillo K, Spiegel CA, Andes DR. 2010. Development and validation of an in vivo Candida albicans biofilm denture model. Infect. Immun. 78:3650-3659. http://dx.doi.org/10.1128/IAI.00480-10.
86. Hwang TL, Shaka AJ. 1998. Multiple-pulse mixing sequences that selectively enhance chemical exchange or cross-relaxation peaks in highresolution NMR spectra. J. Magn. Reson. 135:280-287. http://dx.doi.org/10.1006/jmre.1998.1598.
87. Hwang T, Shaka AJ. 1995. Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulse-field gradients. J. Magn. Reson. 112:275-279. http://dx.doi.org/10.1006/jmra.1995.1047.
88. Dalvit C, Flocco M, Veronesi M, Stockman BJ. 2002. Fluorine-NMR competition binding experiments for high-throughput screening of large compound mixtures. Comb. Chem. High Throughput Screen. 5:605-611. http://dx.doi.org/10.2174/1386207023329923.